Rirong earned his medical doctor degree from Sun Yat-sen University in 2023. During his doctoral training, he performed studies to identify biomarkers for predicting disease prognosis in patients with ulcerative colitis and Crohn’s disease (CD). Since 2025, Rirong has started a postdoctoral fellowship in Mount Sinai Hospital, under the supervision of Dr. Lee and Dr. Croitoru. He is interested in leveraging multi-omics techniques on the CCC-GEM cohort to reveal biomarkers for predicting CD onset and potential targets for intercepting CD development. He is also interested in developing prediction models to identify individuals with high-risk of CD.